Ireland vs Norway: Breast cancer screening coverage in Europe
Ireland
70.3%
in 2022
Norway
76.0%
in 2022
Ireland rank
7th
Norway rank
5th
Breast cancer screening coverage in Europe over time
- Ireland
- Norway
How they compare
Norway currently reports 76.0% against 70.3% in Ireland, a difference of 5.7%.
That makes Norway's figure about 1.1 times Ireland's.
The two have swapped places 3 times across 21 shared years of data; in 2002 it was Ireland ahead.
Ireland ranks 7th and Norway ranks 5th of 26 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ireland | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.3% | 73.4% | 3.9% | Ireland |
| 2010s | 73.6% | 71.3% | 2.3% | Ireland |
| 2020s | 73.2% | 68.1% | 5.1% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer screening coverage in europe, Ireland or Norway?
- Norway, at 76.0% against 70.3% in Ireland as of 2022.
- What is the difference in breast cancer screening coverage in europe between Ireland and Norway?
- 5.7%, with Norway ahead.
- How many years of comparable data are there for Ireland and Norway?
- 21 years are reported by both, from 2002 to 2022.
- How do Ireland and Norway rank globally for breast cancer screening coverage in europe?
- Ireland ranks 7th and Norway ranks 5th of 26 countries.
- Where does this data come from?
- Eurostat (2024) – processed by Our World in Data, published as Breast cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 50 to 69 years who have been screened for breast cancer within the previous 2 years.